GT
CLB icon

Glenmede Trust’s Core Laboratories CLB Stock Holding History

Glenmede Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-476
Closed -$7K – 1408
2020
Q3 		$7K Sell
476
-340
-42% -$7.13K ﹤0.01% 1985
2020
Q2 		$16K Buy
816
+678
+491% +$12.2K ﹤0.01% 1666
2020
Q1 		$5K Hold
138
– – ﹤0.01% 2666
2019
Q4 		$5K Hold
138
– – ﹤0.01% 2666
2019
Q3 		$6K Sell
138
-16
-10% -$744 ﹤0.01% 2554
2019
Q2 		$8K Sell
154
-2,507
-94% -$147K ﹤0.01% 2458
2019
Q1 		$183K Buy
2,661
+2,111
+384% +$142K ﹤0.01% 1205
2018
Q4 		$32K Buy
+550
New +$47.5K ﹤0.01% 1778
2018
Q3 		– Sell
-467
Closed -$59K – 1508
2018
Q2 		$59K Buy
+467
New +$56.8K ﹤0.01% 1390
2017
Q4 		– Sell
-600
Closed -$59K – 2683
2017
Q3 		$59K Hold
600
– – ﹤0.01% 1584
2017
Q2 		$69K Hold
600
– – ﹤0.01% 1487
2017
Q1 		$69K Hold
600
– – ﹤0.01% 1487
2016
Q4 		$72K Hold
600
– – ﹤0.01% 1489
2016
Q3 		$67K Hold
600
– – ﹤0.01% 1508
2016
Q2 		$74K Buy
600
+549
+1,076% +$66.3K ﹤0.01% 1436
2016
Q1 		$5K Sell
51
-51
-50% -$5.3K ﹤0.01% 2197
2015
Q4 		$11K Buy
+102
New +$11.7K ﹤0.01% 2038
2014
Q4 		– Sell
-90
Closed -$13K – 2537
2014
Q3 		$13K Buy
90
+11
+14% +$1.7K ﹤0.01% 2064
2014
Q2 		$13K Sell
79
-20
-20% -$3.56K ﹤0.01% 1989
2014
Q1 		$19K Sell
99
-7
-7% -$1.32K ﹤0.01% 1894
2013
Q4 		$20K Buy
106
+3
+3% +$558 ﹤0.01% 1842
2013
Q3 		$17K Sell
103
-150
-59% -$23.3K ﹤0.01% 1827
2013
Q2 		$38K Buy
+253
New +$35.8K ﹤0.01% 1583

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Glenmede Trust's CLB Position: Q4 2020 in Review

Glenmede Trust sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 476 shares — an estimated $7K sold.

Glenmede Trust first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $183K in Q1 2019. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Glenmede Trust reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 476 Core Laboratories shares in Q4 2020, an estimated $7K.
  • Glenmede Trust first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
  • Glenmede Trust's Core Laboratories position peaked at $183K in Q1 2019.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.